
Aeglea BioTherapeutics AGLE
Annual report 2025
added 02-19-2026
Aeglea BioTherapeutics P/CF Ratio 2011-2026 | AGLE
Annual P/CF Ratio Aeglea BioTherapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -4.6 | -4.33 | -0.0168 | -0.233 | -5.54 | -3.37 | -5.75 | -4.12 | -2.06 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0168 | -5.75 | -3.34 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Agenus
AGEN
|
-0.000958 | $ 3.27 | -1.8 % | $ 1.17 M | ||
|
Agios Pharmaceuticals
AGIO
|
-4.37 | $ 29.33 | -2.98 % | $ 1.7 B | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Akebia Therapeutics
AKBA
|
4.92 | $ 1.26 | -3.44 % | $ 324 M | ||
|
Akari Therapeutics, Plc
AKTX
|
-6.32 K | $ 0.24 | 1.1 % | $ 5.73 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Aldeyra Therapeutics
ALDX
|
-9.8 | $ 5.49 | 0.52 % | $ 330 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Alector
ALEC
|
-1.34 | $ 2.26 | -7.2 % | $ 233 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-0.708 | $ 7.02 | -0.21 % | $ 451 M | ||
|
Alkermes plc
ALKS
|
9.85 | $ 29.32 | -2.61 % | $ 4.83 B | ||
|
Allogene Therapeutics
ALLO
|
-2.97 | $ 2.57 | -7.73 % | $ 403 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
77.9 | $ 330.95 | -0.59 % | $ 43.4 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Altimmune
ALT
|
-5.8 | $ 4.2 | -2.55 % | $ 298 M | ||
|
ALX Oncology Holdings
ALXO
|
-0.625 | $ 2.11 | 0.09 % | $ 110 M | ||
|
Amgen
AMGN
|
19.9 | $ 387.85 | 0.03 % | $ 209 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 20.22 | -0.05 % | $ 945 M | ||
|
Amarin Corporation plc
AMRN
|
64 | $ 13.62 | -1.3 % | $ 5.55 B | ||
|
AIM ImmunoTech
AIM
|
-1.25 | $ 0.92 | 5.25 % | $ 44.2 M | ||
|
AnaptysBio
ANAB
|
-3.41 | $ 54.61 | -0.8 % | $ 1.55 B | ||
|
Anika Therapeutics
ANIK
|
-209 | $ 14.44 | 0.53 % | $ 212 M | ||
|
ANI Pharmaceuticals
ANIP
|
18.7 | $ 75.31 | 1.91 % | $ 1.45 B | ||
|
Annexon
ANNX
|
-2.79 | $ 5.38 | -3.93 % | $ 739 M | ||
|
Annovis Bio
ANVS
|
-2.69 | $ 2.6 | -2.99 % | $ 23.5 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Apellis Pharmaceuticals
APLS
|
61.2 | $ 20.53 | -2.05 % | $ 2.59 B | ||
|
Aptorum Group Limited
APM
|
-3.44 | $ 0.78 | -0.67 % | $ 4.25 M | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Aprea Therapeutics
APRE
|
-1.76 | $ 0.88 | -3.71 % | $ 3.18 M | ||
|
Aptevo Therapeutics
APVO
|
-0.0374 | $ 7.28 | -0.55 % | $ 2.01 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | ||
|
Aquestive Therapeutics
AQST
|
-6.77 | $ 3.99 | -0.15 % | $ 346 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-7.23 | $ 8.11 | -1.44 % | $ 219 M | ||
|
Ardelyx
ARDX
|
-38.2 | $ 6.32 | -3.54 % | $ 1.52 B | ||
|
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | ||
|
argenx SE
ARGX
|
-22.7 | $ 762.51 | -0.58 % | $ 25 B |